We’re committed to supporting investigator-initiated research that promotes the advancement of medical and scientific knowledge involving AbbVie’s products and therapeutic areas of interest.
The research from Investigator-Initiated Studies (IIS) has the capability to expand understanding of our products and their potential applications. Plus, data from investigator-sponsored research can inform patient care and spark new ideas for further disease-related research. The AbbVie IIS Program provides an opportunity for academic and community-based physicians and researchers worldwide interested in conducting their own research to apply for research support.
If you’re an investigator, you can initiate the application process by submitting a brief summary of the proposed research for AbbVie associated products through the: IIS Study Submission Portal.
IIS applications are accepted on a rolling submission basis.
Following the review of the initial submission, you may be asked to submit a full protocol and final study budget for further evaluation. Submission of a proposal does not imply or guarantee approval. The committee evaluates proposals according to scientific merit, alignment with our areas of research interest and available funding. Financial and/or product support is contingent upon full execution of the research agreement by both parties.
Please refer to the following documents to learn more about our 2023 IIS strategic priorities:
For assistance on submitting an IIS application or frequently asked questions, please refer to the following support resources below:
If you are unable to find answers to your questions in the resources above, please contact: [email protected]
For technical support, please contact the appropriate support team below:
Phone: 1-800-252-4415 (toll-free within the US) or follow the International toll-free instructions on the SPIRIT Submission Portal.
The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence. The Internet site that you have requested may not be optimized to your screen size. Do you wish to continue to this product-specific site?